Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:NSPH

(NSPH) (NSPH) Stock Price, News & Analysis

(NSPH) logo

About (NSPH) Stock (NASDAQ:NSPH)

Advanced Chart

Key Stats

Today's Range
$1.69
$1.69
50-Day Range
N/A
52-Week Range
$0.48
$3.64
Volume
N/A
Average Volume
886,293 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.

Receive NSPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter.

NSPH Stock News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More Headlines

NSPH Stock Analysis - Frequently Asked Questions

(NSPH) (NASDAQ:NSPH) announced its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.59) by $0.04. The company's revenue for the quarter was up 43.5% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Meta Platforms (META), Advanced Micro Devices (AMD), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL) and Molecular Templates (MTEM).

Company Calendar

Last Earnings
5/16/2016
Today
1/15/2025

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NSPH
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NASDAQ:NSPH) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners